JPX : 4570.T

Immuno-Biological Laboratories Co., Ltd.

$942 JPY

-$38 (-3.88%)

Volume
140.6K
Average Volume
116.83K
Market Capitalization
$8.77B
P/E Ratio
26.67
Dividend Yield
0.64%
Price Target
Year High
$3820.00
Year Low
$464.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$5.68
Company Overview

JPX

Tsutomu Seito

Biotechnology

Healthcare

4570.T

54

JP

JPY

https://www.ibl-japan.co.jp

81 2 7422 2889

N/A

N/A

Liquidity Metrics

0.10

5.68

4.31

3.58

0.00

Sales & Valuation

$1B

8.73

4.76

0.00

0.00

Profitability

$35.33

$329.02M

32.74%

29.91%

19.25%

15.27%

P/E Metrics

26.67

0.84

0.84

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Poll Results

About Immuno-Biological Laboratories Co., Ltd. (JPX:4570.T) Stock

Immuno-Biological Laboratories Co., Ltd. (IBL) is a global entity dedicated to the research, development, production, and distribution of immunological reagents. The company's diverse offerings include ELISA assay kits designed for the precise quantitative measurement of targeted substances, alongside comprehensive research support services focusing on areas such as Alzheimer's disease, metabolic syndrome, and cancer. IBL also caters to specific client needs through customized services for antibody production and the development of bespoke ELISA systems. A prominent service is LipoSEARCH, which provides tailored lipoprotein profiling and analysis utilizing gel-filtration high-performance liquid chromatography. This advanced method allows for the in-depth examination of even minute plasma o ... r serum samples from both humans and small animals, supporting a broad spectrum of research, including lipid metabolism, the creation of pharmaceuticals for lifestyle-related diseases, functional food development, and clinical investigations. For animal health, IBL offers LipoTEST, a diagnostic and health screening tool for veterinary clinics, complemented by personalized biomarker testing services for lifestyle-related conditions. Furthermore, the company operates an innovative protein production division that leverages transgenic silkworms. This technology is instrumental in manufacturing antibodies for research and diagnostic applications, human collagen for cosmetic use, proteins for drug development, and other specialized proteins. Established in 1982, Immuno-Biological Laboratories Co., Ltd. is headquartered in Fujioka, Japan.

Frequently Asked Questions

What is the current Immuno-Biological Laboratories Co., Ltd. (4570.T) stock price?

Immuno-Biological Laboratories Co., Ltd.(JPX:4570.T) stock price is $942 in the last trading session. During the trading session, 4570.T stock reached the peak price of $3820 while $464 was the lowest point it dropped to. The percentage change in 4570.T stock occurred in the recent session was --3.88% while the dollar amount for the price change in 4570.T stock was -$38.

4570.T's industry and sector of operation?

The JPX listed 4570.T is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of 4570.T?

Shoko Onodera | GM of Human Resources, General Affairs and Internal Audit Office & Director
Masato Nakagawa | MD, Chief Operating Officer, GM of Business Group Administration Division & Director
Tsutomu Seito | Chairman & President
|
|

How many employees does 4570.T have?

Number of 4570.T employees currently stands at 54. 4570.T operates from Fujioka Laboratory, Fujioka, GU 375-0005, JP.

Link for 4570.T official website?

Official Website of 4570.T is: https://www.ibl-japan.co.jp

How do I contact 4570.T?

4570.T could be contacted at phone #81 2 7422 2889 and can also be accessed through its website. 4570.T operates from Fujioka Laboratory, Fujioka, GU 375-0005, JP.

How many shares of 4570.T are traded daily?

The average number of 4570.T shares traded daily for last 3 months was 116.83K.

What is the market cap of 4570.T currently?

The market value of 4570.T currently stands at $8.77B with its latest stock price at $942